Sessions

DEVELOPING A COMMERCIALLY ROBUST SUPPLY CHAIN ACROSS THE EUROPEAN CONTINENT
REVOLUTIONISING VIRAL VECTOR DEVELOPMENT IN EUROPE
EUROPEAN EXPANSION; MANUFACTURING HIGH QUALITY, LOW COST & LARGE VOLUME CELL & GENE THERAPIES
EXPLORING THE SHIFT TOWARDS POINT OF CARE AUTOMATION & DECENTRALISED MANUFACTURING
EUROPEAN SCALABILITY CONSIDERATIONS TO INDUSTRIALISE EARLY ACADEMIC TRANSLATION

DEVELOPING A COMMERCIALLY ROBUST SUPPLY CHAIN ACROSS THE EUROPEAN CONTINENT

31 Aug 2022
15:30
SPONSORED BY
Cell Matters
World Courier Management Ltd

15:30 – CHAIR INTRODUCTION

Chair: Stephen Sullivan, Programme Manager & International Liaison Officer, GAiT

 

15:35 – CASE STUDY

Speaker: Julia Sable, Director CMC Project Management, Tmunity

 

15:50 – CASE STUDY

Speaker: 

 

16:05 – CASE STUDY: HOW THE EUROPEAN QUALIFIED PERSON & BATCH RELEASE IS IMPACTING CELL THERAPY DISTRIBUTION 

Speaker: Andrea Zobel, Senior Director, Personalized Supply Chain, World Courier

 

16:20 – CASE STUDY: FRESH TO FROZEN & INTEGRATION: DE-RISKING THE CELL THEARPY SUPPLY CHAIN 

Ludwig Camusot, Chief Corporate Development Officer, Cell-Matters

 

16:35 – PANEL DISCUSSION

Speakers:

Ludwig Camusot, Chief Corporate Development Officer, Cell-Matters

Julia Sable, Director CMC Project Management, Tmunity

Andrea Zobel, Senior Director, Personalized Supply Chain, World Courier

Speakers

Julia Sable
Director CMC Project Management
Tmunity Therapeutics
Ludwig Camusot
Chief Corporate Development Officer
Cell Matters
Andrea Zobel
Senior Director, Personalized Supply Chain
World Courier Management Ltd
Stephen Sullivan
Programme Manager & International Liason Officer
GAiT